29
Oct
Mumbai (Maharashtra) [India], October 29: Fischer Medical Ventures Limited(FISCHER | 524743 | INE771F01041), one of the leading companies engaged in the business of developing innovative, cost-effective medical imaging, advanced diagnostics and point-of-care diagnostic solutions, has announced its unaudited financial results for Q2 & H1 FY26. Key Consolidated Financial Highlights Q2 FY26 Key Financial Highlights • Total Income of ₹ 88.79 Cr, YoY growth of 122.64% • EBITDA of ₹ 18.74 Cr, YoY growth of 2,511.72% • EBITDA Margin of 21.10%, YoY growth of 1,930 BPS • Net Profit of ₹ 13.96 Cr, YoY growth of 4,659.63% • Net Profit Margin (%) of 15.72%, YoY growth of 1,499 BPS • EPS of ₹ 2.15, YoY growth of 4,200.00% H1 FY26 Key Financial Highlights • Total Income of ₹ 119.70 Cr,…
